BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹100 Cr | ₹74 Cr | ₹81 Cr | ₹-241 Cr | ₹-275 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹81 Cr |
| Mar2022 | ₹-241 Cr |
| Mar2021 | ₹-275 Cr |
How is Deferred Tax Assets / Liabilities of BIOCON Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 34.77 | |
| Mar2024 | ₹74 Cr | -8.17 | |
| Mar2023 | ₹81 Cr | Positive | |
| Mar2022 | ₹-241 Cr | Negative | |
| Mar2021 | ₹-275 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹57,168.3 Cr | 0.3% | -2.9% | 4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 0.3% |
-2.9% |
4.6% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses